Volume 73, Issue 10 pp. 2385-2394
ORIGINAL RESEARCH: EMPIRICAL RESEARCH – QUALITATIVE
Full Access

A qualitative study of community nurses’ decision-making around the anticipatory prescribing of end-of-life medications

Ben Bowers

Corresponding Author

Ben Bowers

Hinchingbrooke Health Care NHS Trust, Huntingdon, Cambridgeshire, UK

Correspondence

Ben Bowers, Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, University Forvie Site, Cambridge, UK.

Email: bbowers@nhs.net

Search for more papers by this author
Sarah A Redsell

Sarah A Redsell

Anglia Ruskin University, Cambridge, UK

Search for more papers by this author
First published: 19 April 2017
Citations: 37

Abstract

Aims

The aim of this study was to explore community nurses’ decision-making processes around the prescribing of anticipatory medications for people who are dying.

Background

Community nurses frequently initiate the prescribing of anticipatory medications to help control symptoms in those who are dying. However, little is known about their decision-making processes in relation to when they instigate anticipatory prescribing and their discussions with families and General Practitioners.

Design

A qualitative interpretive descriptive enquiry.

Methods

A purposive sample of 11 Community Palliative Nurses and District Nurses working in one geographical area participated. Data were collected between March and June 2016 via audio recorded semi-structured interviews and analysed inductively using Braun and Clarke's thematic analysis.

Results

Three themes were identified: (1) Drugs as a safety net. Anticipatory medications give nurses a sense of control in last days of life symptom management; (2) Reading the situation. The nurse judges when to introduce conversations around anticipatory medications, balancing the need for discussion with the dying person and their family's likely response; (3) Playing the game. The nurse owns the decision to initiate anticipatory medication prescribing and carefully negotiates with the General Practitioner.

Conclusion

Nurses view pain control through prescribed medication as key to symptom management for dying people. Consequently, they own the role of ascertaining when to initiate discussions with families about anticipatory medicines. Nurses believe they advocate for dying person and their families’ needs and lead negotiations with General Practitioners for medications to go into the home. This nurse led care alters the traditional boundaries of the General Practitioners-nurse professional relationship.

Why is this research or review needed?

  • The prescribing of anticipatory medications to prevent pain and distress during the last few days of life is common practice.
  • There are significant gaps in knowledge around the process of prescribing which may influence whether drugs are prescribed ahead of need or too late.
  • This research will provide insight and guidance about the process of prescribing decision-making for nurses who are caring for dying people.

What are the key findings?

  • Nurse participants viewed medication as key to symptom management for dying people and having them in the home prior to need represented a safety net.
  • Participants decision-making about the timing of anticipatory medication conversations considered how close to death the person appeared, whilst judging to what extent people were willing to contemplate their impending death.
  • Interestingly, nurses in this study believed they led the decision to enable anticipatory medicine prescribing and led negotiations with GPs over what medications go into the home.

How should the findings be used to influence practice and research?

  • Although nurses draw reassurance from having anticipatory medications available, the views of people who are dying and their families remain unknown. We suggest exploring individuals’ and their families’ perceptions of anticipatory medications should be a research priority.
  • These findings highlight the need to better understanding the prognostic indicators that identify that someone is likely to be entering the last weeks of their life, to help inform the timely initiation of anticipatory prescribing.

1 INTRODUCTION

Ageing populations worldwide are drawing political, public and clinical attention to the need to provide good quality end-of-life home care (Gnomes et al., 2012; World Health Organisation 2016). District Nurses and Community Palliative Nurses (Box 1) have a key role in supporting terminally ill adults to die at home with dignity and respect and in managing pain and other symptoms proactively (Burt, Shipman, Addington-Hall, & White, 2008; Department of Health, 2008; Griggs, 2010; Sandgren, Thulesius, Petersson, & Fridlund, 2007). For some individuals, supporting them to die at home involves putting in place anticipatory medications which can be given if needed to relieve distressing symptoms in their final days of life (Faull, Windridge, Ockleford, & Hudson, 2013; National Institute for Health and Care Excellence, 2015; Wilson, Seymour, & Seale, 2016).

Box 1. Types of roles in the UK

Role Definition
District Nurse (DN) Registered nurses delivering care to adults in their own homes. This includes nurses with the additional District Nursing practitioner qualification.
Community Palliative Nurse (CPN) Registered nurses that focus on providing advice on the management of adults’ palliative symptoms.
Nurse Independent Prescriber (qualification) Nurses who have completed an independent Nurse Prescribing Course. They can prescribe any medicine provided it is within their competency to do so.
General Practitioner (GP) A family doctor who provides general medical treatment for people, usually in the community.

Across the UK, Australia and in some areas of Canada and the USA, anticipatory prescribing has been actively encouraged to minimize the risks of people having uncontrolled symptoms or distress and to prevent unnecessary crisis admissions to hospital (Amass & Allen, 2005; British Medical Association, 2016; Healy, Israel, Charles, & Reymond, 2013; Wowchuk et al., 2009). Anticipatory medications (Box 2) are kept in the home and are primarily administered as injections by practitioners if the person becomes unable to take oral medications and develops symptoms of pain, nausea, agitation or respiratory secretions when they are dying (NICE 2015; Scottish Palliative Care Guidance, 2015.

Box 2. Standard practice for anticipatory medication prescribing

  1. There are three sequential stages in the anticipatory prescribing process: “prescription-writing”, “dispensing” and “administration (Faull et al. 2013). The first stage of the process, the initiating and prescribing of anticipatory medications is critical as without it the rest of the process stops and medications do not become available to administer.
  2. Anticipatory medications are proactively prescribed “if needed”, alongside the equipment needed to administer them, to manage sudden changes in a person's condition when they are dying.
  3. A standard anticipatory prescription would include medication prescribed subcutaneously to treat pain, anxiety / restlessness, nausea and phalangeal / respiratory secretions.
  4. The specific medications prescribed vary depending on the local prescribing algorithms and may include sublingual lorazepam.
  5. Medications, administration equipment, patient information and a signed permission for medical administration chart detailing doses to give based on clinical indications are kept in the person's home. Visiting nurses or doctors would make a clinical assessment before deciding whether to administer any medications (Amass & Allen, 2005; Twycross et al. 2014 p.681; Wilson et al. 2015).

In the UK, public concerns over the now withdrawn Liverpool Care Pathway (LCP) have led to greater scrutiny of end-of-life prescribing practices. The LCP offered an explicit framework for practitioners on patient care in the last days of life (Veerbeek et al., 2008). Neuberger et al. (2013) in their critical review of the LCP's use across the UK, highlighted the dangers of over-sedation when anticipatory medications are prescribed without clear individualized rationale, or involving the person and their families in decision-making. Subsequent last days of life care guidance, replacing the LCP in the UK, has reiterated that individualized anticipatory prescribing is considered part of best practice (National Institute for Health and Care Excellence, 2015; SPCG 2015).

2 BACKGROUND

Community nurses in the UK play a key role in initiating the prescribing of anticipatory medications. Anquinet et al. (2015) in a multiple case study covering Belgium, the Netherlands and the UK, found uniquely to the UK cases, it was the community nurse who encouraged the General Practitioner (GP) to prescribe anticipatory medications in case they became needed. Wilson et al. (2016) surveyed 574 community nurses’ experiences of anticipatory prescribing across two regions of England and found 60% of respondents identified that ‘in approximately 60% of incidents’ they initiated decisions to prescribe medications.

There is insufficient knowledge about the nature of conversations that take place between nurses and/or GPs with individuals and their families around prescribing anticipatory medication (National Institute for Health and Care Excellence, 2015). In two UK qualitative studies, Griggs (2010) and Griffiths, Ewing, Wilson, Connolly, and Grande (2015) found District Nurses perceived that having open and honest conversations with families and patients about the dying process was important in proactively managing symptoms. Although both studies offer insights into District Nurses end-of-life care values and perceptions, neither study explored views nor experiences around anticipatory medications conversations.

Furthermore, there is limited understanding of practitioner's decision-making around the timing of initiating such conversations. Faull et al. (2013), in a qualitative study exploring the challenges in anticipatory prescribing across one area in England, identified that GPs and nurses felt having enough contact with patients to build up a rapport and trusting relationship was central in enabling sensitive and timely conversations. Most participants discussed and prescribed medications ‘a few days’ before actually being needed. Practitioners who initiated anticipatory prescribing a few weeks ahead of need did not perceive any issues providing there was good interprofessional communication.

Nurses initiating the prescribing of anticipatory medications discuss the patient's needs with the individual's GP and ask them to prescribe the drugs (Wilson et al., 2014). Explorative studies show that knowing and trusting other professional's judgements appears central to the successful prescribing of anticipatory medications (Anquinet et al., 2015; Faull et al., 2013). Griggs (2010) identified a lack of knowledge about end-of-life care among GPs together with heavy reliance on nurses to specify what to prescribe. In contrast, the nurses expressed discomfort with having this responsibility placed on them.

The research highlights several linked gaps in knowledge around the prescribing of anticipatory medications which may influence whether drugs are prescribed ahead of need or too late. More explorative research is needed to understand District Nurses and Community Palliative Nurses perspectives on initiating anticipatory prescribing. This knowledge will contribute to our understanding of nurses’ end-of-life home care practice around anticipatory prescribing.

3 THE STUDY

3.1 Aims

The aim of this study was to explore community nurses’ decision-making processes around the prescribing of anticipatory prescribing for people who are dying. The research question was ‘What are community nurses’ perceptions of their decision-making in initiating end-of-life anticipatory medications?’

3.2 Design

This was an interpretive descriptive qualitative study (Thorne, 2008). This inductive methodology is driven by the underlining philosophical argument of letting interpretations of reality around the phenomenon emerge from participant's experiences and views (Weaver & Olson, 2006). Interpretative description particularly lends itself to inductively exploring clinically orientated research questions (Thorne, Kirkham, & MacDonald-Emes, 1997) and recognizes the intricacies of knowledge shaped through researcher-participant interactions (Sandelowski, 2000; Vaismoradi, Turunen, & Bondas, 2013).

3.3 Sample

This study was conducted in a 350-square mile geographical locality covering rural and urban communities in one area of England. Purposive sampling was used to ensure a wide range of nurse stakeholders’ perspectives (Palys, 2008). The inclusion criteria were: Community Palliative Nurses and District Nurses who have had direct clinical involvement in prescribing anticipatory medications to individuals with terminal illnesses. The exclusion criteria were: Community Palliative Nurses and District Nurses with no experience in initiating the prescribing of anticipatory medications or no longer clinically practicing. Community Palliative Nurses were contacted directly by email by the first author. The District Nurses worked in a different NHS Trust to the first author and their clinical lead acted as a gatekeeper, selecting potential participants and forwarding an email invitation to take part.

3.4 Data collection

Data were collected through face to face interviews, using a semi-structured interview guide, between March and June 2016. The interview guide consisted of open-ended questions and prompts to encourage participants to openly convey their views and experiences of putting in place anticipatory medications and their perceptions of their conversations with others in doing so (Tod, 2015 p.391). The interview guide was continually adapted in response to emerging data (Braun & Clarke, 2013, p85). The main focus of the study was on nurses’ decision-making and novel themes around this stopped emerging after nine interviews. Nevertheless, a further two interviews were conducted to ensure we had sufficient context to explain our findings.

Interviews were conducted in a private room at the participant's work base or a hospital site and audio recorded. Interviews ranged from 27 to 57 min in length (mean = 39 min). Important features of each participant's responses and initial ideas for data analysis were documented by the first author in field notes after each interview. These informed the data analysis alongside interview transcripts (Braun & Clarke, 2013 p.93).

3.5 Ethical considerations

Research Ethics Committee approval was obtained from a University's Ethics Committee. Research governance approval was granted by the Trusts employing participants. Written informed consent was obtained prior to interviewing participants’. Discussing end-of-life care experiences, especially events perceived to have not gone well, can cause professional's emotional discomfort (Burt et al., 2008). Participants were given time to debrief after their interview and provided with information on clinical supervision and counselling support. Participants were given the option of pausing interviews or withdrawing from the study at any time, including after data collection, without giving a reason (Tod, 2015 p.396). No participants withdrew from the study.

3.6 Data analysis

Interview recordings were transcribed verbatim to thoroughly capture the language used. Data were interpreted inductively using Braun and Clarke's (2013) phases of thematic analysis. Thematic analysis was adopted for its epistemological fit with interpretative description (Braun & Clarke, 2006; Vaismoradi et al., 2013). This involved transcribing audio data; checking it against recordings for accuracy; familiarization with the data; generating initial codes; searching for themes; reviewing themes; defining and naming themes; producing the report. Transcripts were initially coded by the first author. To ensure a rigorous level of analysis, the second author coded sections of three transcripts independently and the coding decisions were compared and reflected on. This challenged, complemented and informed the developing analysis. An electronic database of codes and data abstracts were compiled using Microsoft Word© and these were revised during the iterative process.

3.7 Rigour

Lincoln and Guba's (1985) trustworthiness criteria were used to ensure researcher-participant's constructed realities were robust and systematic. Descriptions of the setting, data collection methods and the sample's demographic characteristics are presented to enable readers to judge the transferability of findings to their own practice (Lincoln & Guba, 1985 p.316). An audit trail of decision-making processes, in moving from initial codes to final themes, were recorded in field notes. These were reviewed throughout the data analysis process. To ensure a rigorous level of iteration the first author cross-checked key decision points in the thematic analysis process with the second author, including the final candidate themes (Braun & Clarke, 2006; Rapley, 2011).

4 FINDINGS

Eleven community nurses participated in this study: seven Community Palliative Nurses (mean years qualified = 23) and four District Nurses (mean years qualified = 18). Three of seven Community Palliative Nurses (42.9%) and one of four District Nurses (25%) held the Nurse Independent Prescriber qualification (Box 1). Pseudonyms have been used in quotes. Three overarching themes were constructed from the data: (1) Drugs as a safety net; (2) Reading the situation and (3) Playing the game.

4.1 Theme: Drugs as a safety net

Anticipatory medications represent a safety net and give nurses a sense of control in managing an individual's last days of life symptom management. The prospect of a dying person being in distress and a practitioner being unable to act to relieve suffering was psychologically unsettling for nurse participants. They also believed that dying individuals and their families, worried about developing uncontrolled pain or sickness and drew reassurance from knowing anticipatory medications and professional support were there if needed. Nurses felt more in control of the situation if they knew there were drugs available in the home which could be administered if the person quickly deteriorated and became distressed when they were dying:

Not only is it the families comfort, it's for us as well. I feel comfortable knowing they're there, that they're in the house ready because you do have an understanding that they are gradually deteriorating but it can change from day to day. (Alex, District Nurse)

Participants universally felt it particularly important to get medications in place to cover out-of-hour periods when practitioners who know the person are not working. Although there is access to care at these times, nurses worried that individuals might not get effective symptom management, due to out-of-hours GPs not knowing the situation and as it takes time to get medications prescribed and into the home. Conversely, participants did not want to act too prematurely in putting drugs in place. Placing medications in people's homes introduced risks around drugs going missing or being misused. The desire to get medications in place if an individual's death appears imminent is captured in the following comment:

We always try and anticipate when we've got a weekend coming up. Does this person look as though they could probably go downhill? Yes, right we need to get the drugs in before the weekend, because that is our worst nightmare, to not have anything in place. (Carly, District Nurse)

Some nurses focused on the importance of medications in supporting people in their last days of life above other support and psychosocial interventions. Other participants contextualized the role of medications as being just one aspect of holistic care. In the following excerpt, Helen was frustrated that some practitioners did not think beyond anticipatory medications when planning care with families:

I do think sometimes we feel that if we have got the just in case meds [anticipatory medications] that's it we have done everything when it's only the tip of the iceberg if you have got them in there really. (Helen, Community Palliative Nurse)

4.2 Theme: Reading the situation

Nurses judge when to introduce conversations around anticipatory medications, raising the subject in a manner with which they feel is timely and appropriate. Participants perceived that individuals and their families viewed the introduction of anticipatory medications as being a clear signal that the person was closer to death. In the following quote, Chloe recognized that introducing the concept of anticipatory medications into conversations with individuals could cause distress although it could also serve to help people understand that they were dying:

You can see their face sort of go … oh do I need them then, am I going to need them then? Oh now we're talking injections. You can almost hear the cogs working …. it can be a little bit of a warning shot. Things are changing. (Chloe, Community Palliative Nurse)

Respecting an individual's wishes and involving them and their families in deciding when to have medications in the home was central to participants’ decision-making. How information was discussed, around the potential for people to have distressing symptoms in their last days of life, depended on how open individuals and their families were about dying and how comfortable the nurse felt about having these conversations. Some nurses tended to focus anticipatory medication conversations on practical information around what the drugs do and specifically how to access help when needed. Concentrating on practical aspects of care enabled nurses to maintain a more neutral conversation focus. As illustrated in the following extract, this approach to conversations with individuals played down topic areas which might cause people distress:

You would hope to have that conversation to say it may be that we don't need to do any intervention, we have got these drugs just in case … The just in case drugs are there in case we need them, if you need an injection you can have one. (Max, District Nurse)

Participants who voiced a preference to openly explore individual's worries about dying described actively discussing with people what might happen in their last days of life and how this could be managed at home. As shown in the following extract, this helped shift the focus of conversations onto exploring individuals’ concerns, the symptoms they may experience and the type of care that could be realistically provided:

I think sometimes relatives and patients just cope if they know what could happen… talking about just in case medications opens a can of worms about symptoms, about what we can do in the community and what we can't. You know what's feasible and what's not. (Helen, Community Palliative Nurse)

Participants preferred to have built up a rapport with a terminally ill person before opening conversations around end-of-life care planning including anticipatory prescribing. This gave them time to earn the person's trust, understand family dynamics and respond to cues that the person is ready to have end-of-life care discussions. There were situations where people were not ready for medications to go into the home and nurses interpreted this as individuals or their families being in denial about being closer to death. Although participants respected individual's wishes to not think about dying, this caused internal tensions for the nurses. In the following quote, Chloe's ideals of ensuring an individual's autonomy is at the heart of care decisions conflicted with her desire to put in place anticipatory care to facilitate a comfortable and dignified death:

It has to be patient focused and it has to be the right time for them. Equally sometimes you need to… it's hard, that's what makes our job so hard I think. And not to beat yourself up you know if there's not a DNAR [Do Not Attempt Resuscitation decision] in place because they didn't want it, they didn't want it. (Chloe, Community Palliative Nurse)

There were also times when participants had to force end-of-life conversations when they received late referrals and first met a person when they were in their last days of life. As identified in the following extract, end-of-life conversations were perceived as being more challenging if there was insufficient time to build a rapport:

Sometimes there's not enough of a build up … because you've been referred somebody who's very poorly … You're having to get just in case medications on that first day that you meet them and talk about DNAR and all the rest of it and that can be quite overwhelming I think for the patient and their family. (Sue, Community Palliative Nurse)

Nurses found it challenging to accurately predict when someone is likely to die. Participants identified and acted on changes which indicated a person was in the last weeks of their life. These signs included observing when a person was starting to struggle to take oral medications or becoming increasingly fatigued. All the nurses demonstrated an intrinsic knowledge that death was approaching and that it was time to put in place anticipatory medications. As illustrated in the following excerpt, recognizing dying came with experience and at times required picking up on subtle signs:

There might be little hints … ‘You know the last couple of days I've noticed mum's not eating as much as she normally is’. And you think to yourself okay but she's still able to take her medication and then you start think well maybe we should get them [anticipatory medications] in now. (Alex, District Nurse)

4.3 Theme: Playing the game

Getting anticipatory medications in place involves nurses owning the decision to initiate prescribing and carefully negotiating with GPs over what to prescribe. As the practitioners, most frequently visiting individuals at home, participants viewed themselves as acting as the eyes and ears of the GP. They would inform the GP when they felt it was time to get anticipatory medications in place. Nurses believed that most GPs looked to them to initiate these end-of-life care decisions as the nurses were perceived as having more expertise in supporting terminal care:

Actually from what I have experienced generally, the GPs a lot of them, as soon as someone has been deemed palliative, they kind of, they kind of feel a bit out, well I'm not sure they are out of their depth is the right word, they like to pass on a lot of the stuff over to the nurses. (Kelly, District Nurse)

Participants adopted a negotiation tactic to decision-making about medications with GPs. Participants perceived some GPs lacked up to date end-of-life drug knowledge and needed persuading to prescribe for all likely terminal symptoms. If GPs had different prescribing preferences to the nurse, providing these decisions were safe, the nurses would make compromises to avoid damaging their working relationships. Nurses tailored their approach to the GPs knowledge and confidence in end-of-life prescribing. This involved making suggestions on what drugs and doses should be prescribed if the GP asked their advice or the nurse felt they needed to advocate for individuals’ likely needs:

They sometimes say ‘we don't know what to prescribe. You know what it is and what do you think is needed?’ (Max, District Nurse)

It helped when there was an established relationship of trust where the GP and nurse knew and respected each other's clinical skills. This led to effective working relationships where the nurse's views were valued but also vetted by the GP so prescribing decisions were shared. Participants, including those who could independently prescribe medications, preferred decisions to be shared as the GP was perceived to be knowledgeable and ultimately responsible for the person's care. The following quote illustrates that shared decision-making is perceived as being crucial in ensuring drug choices are safe and appropriate:

It's very rare that your suggestions are ignored. The problem is I don't like the doctors that say no to everything and I don't like doctors who say yes to everything, I like the negotiation. (Rene, Community Palliative Nurse)

Participants found that some GPs worried that medications might be used inappropriately. To ensure GPs prescribed medications when the nurse felt they were needed, participants used a variety of tactics to keep GPs up to date with the person's deteriorating condition. These included asking the person to establish regular contact with their GP and discussing the individual's case at multidisciplinary team meetings.

District Nurses tended not to experience conflict in decision-making with GPs. They had established close working relationships with a smaller number of GPs and viewed them as being more knowledgeable about prescribing choices. Conversely, most Community Palliative Nurses experienced occasional conflicts with GPs in prescribing choices particularly when both parties tried to take the lead role in decision-making. Community Palliative Nurses valued specialist expertise over the knowledge of the GP in these situations and recognized this could cause conflict:

They don't always agree with me and sometimes you have to choose your battles, but ultimately you have got to do what's right for the patient … I'm not afraid to be the advocate and push that forward. (Debbie, Community Palliative Nurse)

5 DISCUSSION

This study offers insight into community nurses decision-making around initiating anticipatory prescribing. As Faull et al. (2013) and Wilson, Morbey, Brown, Seale, and Seymour (2015) previously identified, nurses in this study universally believed in the importance of having individually tailored anticipatory medicines available in the home. This study builds on the existing research by illuminating that nurses’ decision-making in initiating prescribing is driven by a desire to give individuals and their families’ reassurance and themselves some control in managing any distressing terminal symptoms. Earlier research suggests that being unable to proactively manage last days of life care and feeling powerless to relieve suffering causes nurses distress and is emotionally draining (Glasberg, Eriksson, & Norberg, 2007; Sandgren et al., 2007). Participants in this study tended to experience heightened emotional tensions when individuals did not wish to consider planning for their last days of life but rationalized that they had done all they could by respecting individuals’ wishes and autonomy.

Medications came across as the predominate intervention nurses perceived could help dying individuals. While this study did not seek out to explore other ways of soothing dying persons, this was not offered by most participants. This may reflect the increasing reliance on medications to resolve or manage problems from both the public and practitioners (Busfield, 2010, 2015). Conversely, Lindqvist et al. (2012) identified that professionals across nine countries acknowledged that non-pharmacological caregiving in last days of life was multifaceted and that the act of being there for people and their families was as important as physically giving care. However, last days of life care guidance is dominated by recommendations around the role of pharmacological interventions (National Institute for Health and Care Excellence, 2015, Scottish Palliative Care Guidance, 2015). Griffiths, Ewing, and Rogers (2010) in a small observational study found community nurses avoided time consuming psychological interventions when they felt out of their comfort zone. The findings of our study suggest that further research is needed into understanding practitioners’ perceptions and use of psychosocial interventions in last days of life care.

Participants’ insights into their conversations around initiating anticipatory prescribing give a voice to previously unheard complex decision-making and skilled conversations. Decision-making around conversations with individuals and their families considered that individuals would perceive the introduction of anticipatory medications as a sign they could die soon. The nurses based their decision-making about the timing of conversations on how close to death the person appeared, while judging to what extent people were willing to have conversations about their impending death.

Identifying that someone is in the last weeks of their life was seen by the participants to be a major antecedent to initiating the prescribing of anticipatory medications. The signs that someone was in the last weeks of their lives are subtle and at times unpredictable (Faull et al., 2013). In this study, it proved difficult for participants to quantify some of the signs they used and this knowledge tended to be learnt through experience. Subtle cues that indicated someone could be in the last weeks of their lives include progressive unintended weight loss, increasing fatigue, dyspnoea and a loss of appetite (Gold Standards Framework 2011, Griffiths et al., 2015). The signs that someone was approaching their last days of their life became clearer as time progressed but waiting risked missing the opportunities to get the medications in ahead of need. Community nurses are ideally placed to spot early signs but they need the training, experience and confidence to know when to act on them. This study supports the need to develop robust prognostic indicators which community practitioners can use to identify the signs that someone is in the last weeks of their lives (National Institute for Health and Care Excellence, 2015).

Participants found it more rewarding and less stressful when they could build relationships of trust with families over several home visits before initiating discussions about end-of-life care. Luker, Austin, Caress, and Hallet (2000) also found that building a rapport with families helps community nurses to uncover individual's understanding of their terminal diagnosis and facilitate discussions about last days of life care. Echoing Luker et al. (2000) observations, if families were culturally open about death and dying, participants in this study were more comfortable starting anticipatory medication conversations earlier. Participants showed a degree of paternalism if they sensed conversations might cause distress. Some nurses tended to explain what the medications were for in a way which played down the risks of developing distressing symptoms. This reflects Millard, Hallett, and Luker (2006) ethnographical observations that the way community nurses involve individuals in decision-making, about their care in the home setting, varies considerably and is shaped by the nurse's preferences and own comfort zone. Nurses ability to engage in interpersonal conversations about end-of-life depends on their experience as well as personal and situational factors. Nurses own comfort zones have a direct impact on the nature of care planning for the dying.

Participants universally prompted the GP to prescribe anticipatory medications when needed. Just as Faull et al. (2013) and Wilson et al. (2016) identified, this study found good interprofessional relationships were crucial in facilitating the prescribing of anticipatory medications. This study adds further insight into the negotiation skills and tactics used by nurses, including leading decision-making when individual GPs were less experienced in end-of-life prescribing. Griggs (2010) concluded that nurses were frustrated and uncomfortable when GPs looked to them to recommend drugs and doses. In contrast, participants in this study believed it was their role to make prescribing recommendations but they also drew on the GPs skills to ensure the best decision was made. Participants who could prescribe independently still wanted the security of sharing decision-making with GPs.

Asking for anticipatory medications to be prescribed, especially controlled drugs, challenges the conventional GP-nurse working relationships where the GP is historically seen to be the expert. Hudson's (2002) multiple site study of community interprofessional working found deep-rooted social and cultural differences remain where GPs are viewed as ‘full professionals’ while nurses are perceived as a ‘semi-professionals’ due to perceived limitations around their knowledge base and autonomy. This study reflects that traditional role hierarchies and boundaries are becoming less distinct in practice. Although, the clinical accountability for prescribing remains with the GP unless the nurse holds an independent prescriber qualification (British Medical Association, 2016). Participants felt GPs were happy with them taking the lead in end-of-life care as the nurse was perceived to be more knowledgeable in this area. This fits with Walshe, Caress, Chew-Graham, and Todd (2010) findings that nurses often take the lead in community palliative care as this helps them exert influence and authority in their relationships with GPs without officially challenging the traditional GP- nurse hierarchy. However, in this study participants experienced conflict when they and the GP both tried to take the lead in decision-making. This may stem from both practitioners gaining emotional satisfaction from overseeing care and working with the individual's and their families (Brown, Sangster, & Swift, 1998; Walshe et al., 2010). In practice, effective decision-making occurs when nurses and GPs have built relationships of mutual respect and have established good lines of communication.

5.1 Strengths and limitations

This study offers insights into nurses’ perspectives on an area of under-researched and important end-of-life care practice. Results from this study cannot be generalized as participants were purposively sampled from one geographical locality. However, the sample size gave a meaningful picture of perceptions across the geographical area (Braun & Clarke, 2013 p45) and may be transferable to similar community settings.

Accessing District Nurses through a gatekeeper created practical difficulties in ensuring a broad range of viewpoints (Oppong, 2013). To abide by data protection laws, it was necessary to accessing potential District Nurse participants through their clinical lead who then selected whom to contact. District Nurses with less experience than the participants who were selected to be contacted may have perceived decision-making differently. Gatekeepers frequently fail to select certain individuals or groups to participate in research studies which can lead to bias towards the views of the selected participants in the findings (Rose, Redsell, & Akister, 2017).

The role of the first author as a clinical researcher and Community Palliative Nurse helped in understanding the culture where participants worked. However, there were times where participants assumed the researcher had pre-existing insight into other aspects of their care and did not elaborate on their practice in the same way they would have with a researcher external to the clinical environment. Similarly, data were interpreted in part through a clinical lens by the first author. Checking developing themes with the second author helped refine analysis and ensured interpretations had credibility (Shenton, 2004).

6 CONCLUSIONS

This study has shown the importance of anticipatory medicine prescribing to nurses’ management of terminally ill people in the community. Nurses believe they have the skills and knowledge to conduct discussions with individuals’ and their families about anticipatory medicines. Nurses in this study largely believed they led the decision to enable anticipatory prescribing and led negotiations with GPs over what medications go into the home. However, the ultimate prescribing responsibility and accountability remains with the GP. To better understand what happens in practice, it would be helpful to explore GPs perspectives of anticipatory prescribing and their decision-making processes. Modern health care is underpinned by notion of a ‘pill for every ill’ and this can influence nurses’ decision-making. However, this approach can overlook the importance of psychosocial support in the last few days of life which may be as timely and valuable.

The findings of this study highlight that nurses perceive individuals and their families take reassurance from having anticipatory medications available. However, the views of people who are dying and their families are unknown. It is pertinent to determine their perception of anticipatory medications and how these fit with their care experience, including any unmet needs. In addition, decisions to instigate anticipatory medication prescribing are reliant on practitioners identifying that individuals are in their last weeks of life. The nurses in this study at times relied on tacit knowledge to identify that someone was approaching death. Research into the prognostic indicators community practitioners use, to identify that someone is likely to be entering the last weeks of their life, would inform the timely initiation of anticipatory prescribing.

CONFLICTS OF INTEREST

No conflict of interest has been declared by the authors.

AUTHOR CONTRIBUTIONS

All authors have agreed on the final version and meet at least one of the following criteria [recommended by the ICMJE (http://www.icmje.org/recommendations/)]:

  • substantial contributions to conception and design, acquisition of data or analysis and interpretation of data;
  • drafting the article or revising it critically for important intellectual content.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.